Skip to main navigation
MoonLake MoonLake
e: info@moonlaketx.com
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
Site - Main
  • About us
    • About MoonLake TX
    • Careers
    • Team
  • Science
    • The science
    • Therapeutic focus
    • Pipeline
  • Investor relations
    • Investors overview
    • Stock information
    • Press releases
    • Events & presentations
    • Corporate governance
    • Financials & filings
    • Email alerts
e: info@moonlaketx.com

INVESTOR RELATIONS

SEC Filing Details

Document details

Form
8-K/A
Filing Date
May 16, 2022
Document Date
Apr 5, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
MoonLake Immunotherapeutics
Issuer
MOONLAKE IMMUNOTHERAPEUTICS

Filing formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
Site - Investor Tools
Print Page
RSS Feeds
Email Alerts
Contact IR

Contact Us

MoonLake Immunotherapeutics Dorfstrasse 29, 6300 Zug, Schweiz/Switzerland
e: info@moonlaketx.com 
media: media@moonlaketx.com 
IR: ir@moonlaketx.com
 
LinkedIn 

Quick Links

  • Home
  • About us
  • Team
  • Science
  • Pipeline
  • Therapeutic focus
  • Investor relations
  • Careers
  • Privacy policy

© 2026 -  MoonLake Immunotherapeutics

Privacy Policy